Quintessence in Biological Technology

Quintessence Secures Financing

... MADISON, WI. - quintessence Biosciences, Inc., a biotechnology company develop...rman and CEO of the company. "Im thrilled that quintessence was able to bring in $2.3M during these tough fina...ith the financial support that his newest company, quintessence Biosciences, has received, it has been placed in t...

Americas Third Coast nurtures biotechnology

...fication of leads during drug development. At quintessence Biosciences ( www.quintbio.com ), researchers are...c to cancer cells, says Ralph Kauten, president of quintessence Biosciences. The basis of the Evade technology inv...etting a later start, the Evade ribonucleases from quintessence Biosciences may be better because they are derived...

Forbes highlights Wisconsin biotech, names Madison #1 business city

...umni Association is a driving force for Madisons biotechnology industry. Companies mentioned included TomoTherapy, Stratagen, Bone Care International, quintessence Bioscience, Alfalight, Epic Systems and Opgen. Big hitters like DeLuca attract big bucks to the university, wrote Tatge referring to the University...

UW Office of Corporate Relations nears one-year mile-mark

...ets of UW to the business world, Stickler added. Company testimonial quintessence Biosciences , a biopharmaceutical company located in University Research Park, is utilizing OCRs media resources. According to Laura Strong, quintessence Biosciences vice president, the company is working with OCR on a business p...

Quintessence Biosciences forms cancer therapeutic advisory board

... MADISON quintessence Biosciences, Inc. has formed a scientific advisor...lement the scientific and medical knowledge within quintessence Biosciences, Inc. They will also assist the compan...ple at some point during their life, Kauten said. quintessence Biosciences must have access to the best medical a...

Doyle announces new small business tech transfer award

...siness experts from around the state has been be selected to review applications: Cory Nettles, secretary of the Department of Commerce; Ralph Kauten, quintessence Biosciences; Mark Burwell, Urban Hope Entrepreneur Center ; Peter Zaballos, Frazier Technology Venture vice president; Dr. Phil Sobocinski, Office of ...

Ralph Kauten on how to raise angel financing

...eeds of your customers. In 2002, Kauten joined quintessence Biosciences, an early-stage biosciences company f... according to plan, the solution being proposed by quintessence Biosciences will be the perfect replacement for ch...nd without becoming infertile. Kauten expects that quintessence Bioscience will be able to run the first human tre...

Cancer treatment advances as trials show no harm to mice

... quintessence Biosciences, Inc. , has been tested on lab mice wi...ong said. The therapeutics under development at quintessence are based on technology created by Ronald Raines ...President Ralph Kauten said. Prior to joining quintessence in 2002, Kauten held management positions in sever...

Wisconsin entrepreneurs need to self-promote like coastal rivals

...tment for these diseases at the earliest possible stages. Madison-based quintessence Biosciences is developing novel cancer therapies, including a cancer cytot...fects. If everything goes according to plan, the solution being proposed by quintessence Biosciences will allow patients to fight cancer without losing their hair, ...

Investors hear about new agricultural technology

...re arent too many companies like us." Ralph Kauten, chairman and CEO of quintessence Biosciences , was invited to speak about both his companys current investme...his companys most recent investments. Kauten focused on the process that quintessence Bioscience used to determine the technology, not necessarily the company, t...

Madison biotechs get Commerce grants

...d Scott Fulton, a BioSystem representative. The second grant recipient, quintessence Biosciences of Madison will receive $15,000. The company develops protein-...ent, and speed up the process of product development," said Ralph Kauten, a quintessence representative. The Technology Assistance Grant program offers grants of...

Technology grants, Bone Care merger

...velopment projects from the Department of Commerce Technology Matching Grant (TMG) and Technology Venture Fund (TVF) Programs. The three companies are quintessence Biosciences, Inc., GWC Technologies, Inc., and Bell Brook Labs, LLC, Meanwhile U.S. Federal Trade Commission has fast-tracked Bone Care's proposed me...

UW's Waisman Center seeing strong demand for biomanufacturing facility time

... cost, Keach said. Among them is Madison-based quintessence Biosciences Inc., which is working with the Waism...ne extremely well," he said. The next stage for quintessence will be to focus on use of the protein purificatio...ct the availability of services for companies like quintessence Biosciences." He foresees a growing demand for ...

Embracing failure is a necessary step for successful entrepreneurs

... learned from its own mistakes. Ralph Kauten, president of Madison-based quintessence Biosciences, described how his company was launched with a portfolio of fiv...think theyre going to work. After much time and investment, Kauten said, quintessence eventually set aside the first technology and moved to developing what the ...

Panel stresses drawing outside biotech firms to state

...other industry to come in, large industry to come in, said audience member Laura Strong, vice president of product development for UW spin-off company quintessence Biosciences. But really focusing on what are our strengths, what can we offer that other areas cant, I think thats a topic of conversation that doesnt...

Wisconsin companies on the front lines in the war against cancer

...ectar, a Madison company, is researching a compound called NM404 that has been shown to identify and shrink a variety of malignant tumors in mice. quintessence Biosciences in Madison has developed a human protein that has been genetically modified so it is toxic to cancer cells. Third Wave Technologies in...

Quintessence division to develop drug tests with NIH grant

...Institutes of Health and formed partnerships with UW-Madison and the University of Helsinki, Finland, to develop new drug tests. QBI, a division of quintessence Biosciences Inc. in Madison, will be working a way to find early indicators of potentially harmful interactions between different drugs given to the s...

QBI's PreserveX product passes initial test

... that we have," Kauten said. Evasive capital? QBI is a division of quintessence Biosciences, Inc ., which is seeking between $5 million and $10 million in ...en modified to produce a drug that is toxic to cancer cells. Kauten said quintessence would like to start the human clinical trials by the end of 2007, and has b...

QBI Life Sciences snags $130,000 NIH grant

... Madison, Wis. - QBI Life Sciences , a division of quintessence Biosciences specializing in tools and reagents for life science research, ...yze multiple levels of the components and their drug attachment. QBI and quintessence Chief Executive Officer Ralph Kauten said that the treatment is designed to...

Quintessence cancer treatment chosen for clinical studies

... Madison, Wis. - quintessence Biosciences , a biopharmaceutical company developing cancer therapies, has ... lung, prostate, and ovarian tumors. Of the 30 EVade ribonucleases that quintessence has tested, QBI-139 had the broadest efficacy in multiple tumor lines. ...

Quintessence Biosciences names new president

... Madison, Wis. - Laura Strong, who has served as vice president of quintessence Biosciences since the year 2000, has been appointed president and chief op...ss toward human clinical trials, which are expected to begin in early 2008. quintessence is focused on developing cancer therapies. Strong's appointment follows ...

Quintessence Biosciences advances cancer drug

...toxicology data indicates that the lead cancer drug candidate of Madison's quintessence Biosciences has met two important preconditions set by the Food and Drug ...pany's EVade ribonuclease development program. The AACR meeting provides quintessence with an opportunity to report information on its emerging drug candidates, ...